Jack Nielsen's Net Worth
Jack Nielsen's net worth is estimated to be at least $53,373,093.62 as of 11/23/2024. CoreStreet's estimation of Jack Nielsen's net worth is based on their sale of stock and current holding of stock.
Jack Nielsen is Director at Harmony Biosciences Holdings. They have executed at least 32 trades of stock as per SEC Form 4 filings. Their most recent trade was for 9,847 units of HRMY stock on 12/09/2022. Their biggest sale was on 07/07/2022 when they sold 180,838 units of Harmony Biosciences Holdings stock for $10,128,736.38. They typically trade 10 times per year.
Total value of insider buys:
- $230,875.10
Total value of insider sells:
- $53,142,218.52
Most recent insider trade:
- Dec. 9, 2022
Jack Nielsen's Insider Trading History
Harmony Biosciences Holdings | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Dec. 9, 2022 | Director | 9,847 | $59.89 | Sell | $589,736.83 |
Dec. 7, 2022 | Director | 64,026 | $60.35 | Sell | $3,863,969.10 |
Dec. 1, 2022 | Director | 65,652 | $60.00 | Sell | $3,939,120.00 |
Nov. 29, 2022 | Director | 21,333 | $57.82 | Sell | $1,233,474.06 |
Nov. 21, 2022 | Director | 24,898 | $57.08 | Sell | $1,421,177.84 |
Nov. 18, 2022 | Director | 20,800 | $57.00 | Sell | $1,185,600.00 |
Nov. 14, 2022 | Director | 58,667 | $58.70 | Sell | $3,443,752.90 |
Aug. 8, 2022 | Director | 75,000 | $53.56 | Sell | $4,017,000.00 |
Aug. 2, 2022 | Director | 75,117 | $55.22 | Sell | $4,147,960.74 |
July 18, 2022 | Director | 40,087 | $55.19 | Sell | $2,212,401.53 |
July 13, 2022 | Director | 5,773 | $55.04 | Sell | $317,745.92 |
July 7, 2022 | Director | 180,838 | $56.01 | Sell | $10,128,736.38 |
July 5, 2022 | Director | 32,486 | $52.27 | Sell | $1,698,043.22 |
July 1, 2022 | Director | 11,038 | $52.04 | Sell | $574,417.52 |
June 29, 2022 | Director | 3,533 | $52.20 | Sell | $184,422.60 |
June 27, 2022 | Director | 86,209 | $52.37 | Sell | $4,514,765.33 |
June 24, 2022 | Director | 11,528 | $52.06 | Sell | $600,147.68 |
April 20, 2022 | Director | 30,177 | $52.14 | Sell | $1,573,428.78 |
April 18, 2022 | Director | 4,195 | $52.14 | Sell | $218,727.30 |
April 14, 2022 | Director | 13,668 | $52.08 | Sell | $711,829.44 |
April 12, 2022 | Director | 19,955 | $50.05 | Sell | $998,747.75 |
April 7, 2022 | Director | 5,266 | $50.25 | Sell | $264,616.50 |
April 4, 2022 | Director | 1,027 | $50.00 | Sell | $51,350.00 |
April 1, 2022 | Director | 2,375 | $50.00 | Sell | $118,750.00 |
March 30, 2022 | Director | 27,851 | $50.24 | Sell | $1,399,234.24 |
March 28, 2022 | Director | 42,489 | $50.82 | Sell | $2,159,290.98 |
March 24, 2022 | Director | 18,935 | $50.12 | Sell | $949,022.20 |
March 22, 2022 | Director | 6,576 | $50.13 | Sell | $329,654.88 |
March 17, 2022 | Director | 5,896 | $50.05 | Sell | $295,094.80 |
Aug. 24, 2020 | Director | 3,057 | $34.30 | Buy | $104,855.10 |
Aug. 20, 2020 | Director | 2,736 | $35.00 | Buy | $95,760.00 |
Reata Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Aug. 22, 2016 | Director | 1,780 | $17.00 | Buy | $30,260.00 |